Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adwin Plus is an oral combination drug developed and marketed by Thrift Pharmaceuticals. It contains two active ingredients: paracetamol (acetaminophen), a widely used analgesic and antipyretic, and domperidone, a dopamine receptor antagonist that acts as an antiemetic and prokinetic agent. This combination is formulated as oral tablets and a paediatric oral suspension, and is typically used to treat pain and fever accompanied by nausea or vomiting. Paracetamol works by inhibiting prostaglandin synthesis in the central nervous system to alleviate pain and reduce fever, while domperidone blocks peripheral dopamine receptors in the chemoreceptor trigger zone and gastrointestinal tract to prevent nausea and vomiting and facilitate gastric emptying.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adwin Plus.